Get started
Author

Aoi Machida

Institution: Fukuyama University
Observed institution: Fukuyama University
ORCID: 0009-0001-9892-3465
Observed ORCID: 0009-0001-9892-3465
OpenAlex ID: A5044072973
Long-term Stimulation of α7 Nicotinic Acetylcholine Receptor Rescues Hemorrhagic Neuron Loss via Apoptosis of M1 Microglia
2023 · Masatoshi Ohnishi, Aoi Machida, et al. · Journal of Neuroimmune Pharmacology · 7
Development of a Water-Soluble Nanomicellar Formulation Loaded with Trans-Resveratrol Using Polyethylene Glycol Monostearate for the Treatment of Intracerebral Hemorrhage
2024 · Kengo Banshoya, Aoi Machida, et al. · Pharmaceutics · 6
Aroma of citral repels mice and exerts antioxidant effects as a functional food
2024 · Masatoshi Ohnishi, Kengo Banshoya, et al. · Flavour and Fragrance Journal · 6
PDF
A Glycyrrhizin Derivative with a More Potent Inhibitory Activity against High-Mobility Group Box 1 Efficiently Discovered by Chemical Synthesis Inspired by the Bioconversion Products of an Endophytic Fungus Isolated from Licorice
2024 · Aoi Machida, Kengo Banshoya, et al. · Journal of Medicinal Chemistry · 5
Preparation and in vitro evaluation of amphotericin B-loaded nano-formulations for both intravenous and ophthalmic administration using 3-aminophenylboronic acid-conjugated styrene-maleic acid copolymers
2023 · Kengo Banshoya, Yoshiharu Kaneo, et al. · Journal of Drug Delivery Science and Technology · 5
Thrombin-induced kynurenine 3-monooxygenase causes variations in the kynurenine pathway, leading to neurological deficits in a murine intracerebral hemorrhage model
2024 · Masatoshi Ohnishi, Kengo Banshoya, et al. · Journal of Pharmacological Sciences · 4
Development of an Injectable Formulation of a Water-Insoluble Glycyrrhizin Derivative That Potently Inhibits High-Mobility Group Box 1 in Murine Intracerebral Hemorrhage
2025 · Aoi Machida, Kengo Banshoya, et al. · Molecular Pharmaceutics · 2
Therapeutic Potential of Water-Soluble Resveratrol-Loaded Polyethylene Glycol Monostearate Micelles in a Mouse Model of Dry Eye Disease
2026 · Aoi Machida, Kengo Banshoya, et al. · Die Pharmazie · 1
PDF
Evaluation of BPA-Bearing TAT-Lipopeptide-Modified Liposomes for Boron Neutron Capture Therapy from Cell-Associated Boron Delivery to In Vivo Tolerability
2026 · Makoto Shirakawa, Alexander Zaboronok, et al. · Pharmaceutics
A styrene–maleic acid copolymer-based boron carrier for tumor-retentive boron delivery in boron neutron capture therapy
2026 · Kengo Banshoya, Makoto Shirakawa, et al. · International Journal of Pharmaceutics
Solubilization of insoluble glycyrrhizin derivative having anti-HMGB1 effect and its biological activity
2023 · Aoi Machida, Kengo Banshoya, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
Exploration of glycyrrhizin derivatives exploiting bioconversion by endophyte inside licorice root.
2023 · Akiho Miyamaru, Kengo Banshoya, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
Long-term stimulation of α7 nicotinic acetylcholine receptor selectively suppresses thrombin-polarized M1 microglia
2022 · Masatoshi Ohnishi, Aoi Machida, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
Works count: 13
Citation count: 36
H-index: 5
I10-index:
Year
Topic
Type